SAN DIEGO, May 8 /PRNewswire-FirstCall/ -- Santarus, Inc. (Nasdaq: SNTS) today announced that a live audio webcast and accompanying slide presentation will be provided for its analyst day and investor briefing event "Santarus: What's New?".
Details of the event are as follows:
What: Santarus: What's New? Analyst Day and Investor Briefing When: Wednesday, May 13, 2009 at 4:15 p.m. Eastern time Where: www.santarus.com (under the Investor Relations link)
Martha Hough, Vice President, Finance & Investor Relations, Santarus, Inc.
Santarus - What's New?
Gerald Proehl, President, Chief Executive Officer & Director, Santarus, Inc.
Commercial Update - ZEGERID(R)/GLUMETZA(R) and Overview of Lower GI Markets
William Denby, Senior Vice President, Commercial Operations, Santarus, Inc.
MMX(R) Technology - The Benefits of Targeted Delivery to the Colon
Dr. Luigi Moro, Chief Scientific Officer, Cosmo Pharmaceuticals
Inflammatory Bowel Disease - A New Horizon
Dr. Simon Travis, Consultant Gastroenterologist, John Radcliffe Hospital, Oxford, United Kingdom; Chairman of the Scientific Committee of the European Crohn's and Colitis Organization
Budesonide MMX(R) - Clinical Development Program in Ulcerative Colitis
Dr. E. David Ballard II, Senior Vice President, Clinical Research & Medical Affairs, Santarus, Inc.
Traveler's Diarrhea - #1 Health Risk for Travelers to Developing Countries
Dr. Robert Stef
|SOURCE Santarus, Inc.|
Copyright©2009 PR Newswire.
All rights reserved